Since the start of mass vaccination against COVID-19 , millions of people worldwide have accessed the various available doses as a key tool to curb the pandemic. The application of these vaccines significantly reduced severe cases , hospitalizations , and mortality , marking a turning point in the global health crisis. Over time, as clinical data accumulated, reports of rare side effects began to circulate , leading to a more in-depth analysis by the scientific community
One of the issues that garnered the most attention was myocarditis , an inflammation of the heart muscle that, in a few specific cases, was detected after the administration of certain COVID-19 vaccines. Myocarditis is not a new disease nor is it exclusive to vaccination: it can occur as a result of viral infections, immune responses, or various medical conditions. In the context of vaccines, studies indicated that its occurrence is rare and that, in most cases, it has a favorable outcome.
